Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD, Daniel V. Mullany, FCICM, John F. Fraser, PhD, FCICM The Annals of Thoracic Surgery Volume 94, Issue 2, Pages 460-467 (August 2012) DOI: 10.1016/j.athoracsur.2012.04.005 Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Five-year (60-month) Kaplan-Meier survival curves in patients transfused with red blood cells (RBC) alone, other blood products, both RBC and other products versus not transfused. The Annals of Thoracic Surgery 2012 94, 460-467DOI: (10.1016/j.athoracsur.2012.04.005) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Five-year (60-month) Kaplan-Meier survival curves in patients who received massive transfusion compared with red blood cells (RBC) alone versus no transfusion. The Annals of Thoracic Surgery 2012 94, 460-467DOI: (10.1016/j.athoracsur.2012.04.005) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions